GL1X · GenesisL1 explorer

MolNFT v1 · #94737 · protein

Selective & brain-permeable polo-like kinase-2 (plk-2) inhibitors that reduce -synuclein phosphorylation in rat brain

4I5M · SERINE/THREONINE-protein kinase PLK2: “Selective & brain-permeable polo-like kinase-2 (plk-2) inhibitors that reduce -synuclein phosphorylation in…”. X-ray diffraction, 1 ligand (R78), 1 pocket (best druggability 0.66). MolNFT v1…

PDB
4I5M
Type
protein
Length
273 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
SERINE/THREONINE-protein kinase PLK2
EC
2.7.11.21
UniProt
Q9NYY3
Ligands
R78
Pockets
1 · best druggability 0.66

Structure

x-ray diffraction · 1 distinct chain · 36% helix, 19% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ASERINE/THREONINE-protein kinase PLK2 (EC 2.7.11.21)protein27336% helix, 19% strandQ9NYY3

Ligands and binding sites

  • R78 · 4-{[(7R)-8-cyclopentyl-7-ethyl-5-methyl-6-oxo-5,6,7,8-tetrahydropteridin-2-yl]amino}-3-methoxy-N-(1-methylpiperidin-4-yl)benzamide · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13810.660.8038R78

Compared structures

  • 4I5M · Selective & Brain-Permeable Polo-like Kinase-2 (Plk-2) Inhibitors that Reduce -Synuclein… · the same entry in another collection · chain A against A, TM-score 1.00
  • Q9NYY3 · AlphaFold monomer V2.0 prediction for SERINE/THREONINE-protein kinase PLK2 (Q9NYY3) · a predicted model of the same protein · chain A against A, TM-score 0.97

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.